CATEGORIES
CATEGORIES

19. February 2024
ARQIS advises Omnes Capital on a majority stake in EEF Erneuerbare Energien Fabrik

ARQIS has advised Omnes on a majority shareholding in EEF Erneuerbare Energien Fabrik GmbH.

With the financial support of Omnes, EEF will drive forward the energy transition 2.0 and the decarbonization of the energy market as an expert in the development, implementation and long-term operation of renewable energy projects. With three locations in Berlin, Hamburg and Wiesbaden and an experienced team along the entire value chain, EEF is excellently positioned to develop projects with the necessary technical expertise close to the location and to reshape the landscape of the energy market. Under the leadership of the three co-partners and managing directors Roman Bredlow, Niklas Hinz and Nigel Nyirenda, EEF is paving the way to a sustainable future with innovative energy solutions.

Omnes is a major player in the renewable energy and infrastructure sectors with approximately €6 billion in assets under management. As an entrepreneur-led investor, Omnes, through its funds, provides its partners with the equity they need to grow and meet the challenges of the energy transition. The investment in EEF was realized through Capenergie 5, which is Omnes' fifth fund focused on renewable energy. The team led by ARQIS partner Dr. Mirjam Boche regularly advises Omnes Capital, including on the investment in the Austrian-German photovoltaic specialist CCE and the investment in the pan-European PV developer Ilos Projects.

The three co-shareholders of EEF Erneuerbare Energien Fabrik were advised by Dr. Michael Burg, co-founder and partner of the law firm Lighthouse Legal.

 

Advisors to Omnes Capital

ARQIS (Dusseldorf): Dr. Mirjam Boche (lead partner, M&A), Conrad Wiza (M&A), Dr. Nima Hanifi-Atashgah (M&A), Martin Weingärtner (employment law), Rolf Tichy (IP)


14. February 2024
ARQIS enters the Legal 500 ranking of leading law firms in Germany with another practice area

ARQIS has once again been listed as a recommended law firm in the recently published guide by The Legal 500 Germany in the specialist areas of labour law, corporate law, M&A and private equity (transactions: medium-sized deals) as well as insurance law (dispute resolution). For the first time, the law firm was also included in the ranking for public law (environmental and planning law). ARQIS was listed as a "Firm to watch" in the area of insurance law (advice to insurance companies). ARQIS thus joins two other areas in the Legal 500 ranking of leading law firms in Germany.

 

HR.LAW

In the Legal 500 Germany rankings, ARQIS achieved Tier 4 out of 7 in the employment law category, highlighting its support for transformation and restructuring projects, including outsourcing and staff reduction measures, a key area of expertise that is covered by practice group head Dr. Andrea Panzer-Heemeier among others, while she also focuses on works council remuneration. The client evaluation states: “This advisory focus is supplemented by expertise in employment law matters relating to IT, data protection and compliance; Lisa-Marie Niklas and Tobias Neufeld who is also experienced in company pension schemes, are among the key contacts in this area.”

The core team also includes counsel Anja Mehrtens, who often uses her expertise in company pension schemes and compliance with employment law regulations in the context of transactions. The team is said to provide “very competent and, above all, binding advice in all matters of employment law.” It continues: “This is paired with great personal commitment and a very good knowledge of the specific requirements of our industry”

 

TRANSACTIONS

In the area of corporate law, the law firm once again maintains tier 4 out of 5 and in M&A (medium-sized deals €100; - €500M) ARQIS is also once again listed in tier 5 out of 6. The team, consisting of Dr. Jörn-Christian Schulze, Dr. Shigeo Yamaguchi, Dr. Mirjam Boche, Dr. Mauritz von Einem and Dr. Christof Alexander Schneider, is said to work “always very solution-oriented and close to the client”. “Our special requirements and wishes are always taken into account. The implementation always takes the form of practicable ideas.”

Tier 5/5 was achieved in the area of private equity (transactions: medium-sized deals).

 

RISK

ARQIS is ranked in Tier 5 out of 5 in the area of insurance law (litigation). This area is led by Dr. Mirjam Boche. Dimitrios Christopoulos is named as the central contact for in-court and out-of-court disputes that the law firm handles for insurers and policyholders.

ARQIS is listed as a “Firm to watch” for the first time in the insurance advice category (insurance law), which is a special tribute to the work of the team led by Dr. Mirjam Boche in recent years.

 

REGULATORY

The category of environmental and planning law (regulatory law) deserves special mention: ARQIS is ranked here for the first time with 5 out of 5. While ARQIS was listed as a “firm to watch” in the environmental and planning law category last year, the regulatory law focus group with Dr. Friedrich Gebert and Dr. Astrid Seehafer achieved a Tier 5 out of 5 ranking this year. The practice group, which was founded in 2021, is particularly highlighted in connection with advice on ESG issues and the energy transition. “These two areas are covered by practice group head Friedrich Gebert, who is also increasingly advising on planning law mandates. Astrid Seehafer joined the team in August 2022 from Freshfields Bruckhaus Deringer and advises on product compliance.”

 

The Legal 500 Germany analyzes law firms and lawyers in interviews with lawyers and clients in a total of 23 practice areas and 90 rankings every year.


25. January 2024
ARQIS advises the shareholders of PRI Pneumologisches Forschungsinstitut and KLB Gesundheitsforschung Lübeck

ARQIS has advised the previous shareholders of Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH (PRI) and KLB Gesundheitsforschung Lübeck GmbH (KLB) on the sale of their shares in the institutes to Velocity Clinical Research.

Since its foundation 25 years ago, the PRI has conducted over 300 studies and is one of Europe's leading institutes in clinical research on bronchial asthma, COPD, bronchiectasis and pulmonary fibrosis. Dr. Anne-Marie Kirsten and Dr. Henrik Watz both continue to work at Velocity as Principal Investigator and Head of Clinical Trials respectively.

The KLB is located in the heart of the city of Lübeck and has been conducting clinical trials on respiratory diseases since 2008. It is dedicated to researching new active principles and diagnostic procedures in the treatment of chronic obstructive airway diseases such as bronchial asthma or smoker's lung/COPD. Dr. Andrea Ludwig-Sengpiel will also continue to work for Velocity in a leading role at the institute.

Velocity is the leading integrated network of clinical trial sites. With nearly 100 clinical trial sites and more than 220 researchers, Velocity works with pharmaceutical and biotechnology companies to discover new drugs, medical devices, diagnostics and combination products that could improve people's health and well-being. Velocity offers unified solutions for research sites to efficiently find the right patients, investigators and research collaborators for clinical trials in the U.S. and Europe.

Both the PRI and the KLB are independent entities. They have been sold together.

The ARQIS team, led by Dr. Jörn-Christian Schulze, won the mandate through a pitch. The pitch was managed by the financial advisor WMCF Advisory. The WMCF team consisted of Ulf Boenicke (Managing Partner), Pascal Florczak (Director), Alexej Koslov (Senior Associate) and Nicolas Emig (Analyst). Both firms are deeply rooted in the healthcare sector and have worked together on numerous other transactions, most recently on the sale of m.doc GmbH to CompuGroup Medical AG.

 

Advisors to PRI and KLB

ARQIS (Dusseldorf): Dr. Jörn-Christian Schulze (Lead), Dr. Maximilian Backhaus, Laura Ally Rizzi (all Transactions); Counsel: Jens Knipping (Tax), Anja Mehrtens (Employment); Associates: Jasmin Grünen (Transactions), Anna Munsch (Employment); Legal Specialists: Qing Xia (Transactions)


19. December 2023
ARQIS advises Fit Reisen on the sale of KMW Reisen to HomeToGo

ARQIS has advised Fit Reisen on the sale of KMW Reisen GmbH to HomeToGo. KMW Reisen GmbH (KMW) operates a leading online travel portal for short trips in the DACH region at kurz-mal-weg.de. Founded in 2001, the online pioneer Kurz Mal Weg has been part of the Fit Reisen Group (fitreisen.de) based in Frankfurt am Main since 2016.

HomeToGo was founded in 2014 and makes holiday accommodation easily accessible to everyone. Since then, the listed Berlin-based company has grown steadily and has developed into the SaaS-enabled marketplace with the world's largest selection of holiday accommodation (over 15 million offers). HomeToGo SE is listed on the Frankfurt Stock Exchange under the ticker symbol “HTG”.

Simultaneously with the acquisition of KMW Reisen GmbH from Fit Reisen, HomeToGo acquires a majority stake in Super Urlaub GmbH. As a result of this transaction, HomeToGo will hold a 51 per cent majority stake in the combined company. This includes the two brands Kurz Mal Weg and Kurzurlaub, two leading specialists for themed holidays and hotel offers for short trips in the DACH region and neighbouring countries.

The sale of the two companies took place as part of a bidding process led by Carlsquare as M&A advisor. The parties have agreed not to disclose the purchase prices.

The leading ARQIS partner of this mandate, Dr Lars Laeger, already advised Fit Reisen on the acquisition of the business of KMW Reisen GmbH from the insolvency of the former Unister Group.

 

Advisors for Fit Reisen

ARQIS (Dusseldorf): Dr. Lars Laeger (Federführung; M&A), Thomas Chwalek (M&A), Johannes Landry (M&A), Lisa-Marie Niklas (Arbeitsrecht), Marcus Nothhelfer (IP); Counsel: Jens Knipping, Dennis Reisich (beide: Steuern); Managing Associates: Dr. Denis Schütz (M&A); Associates: Katrin Ludwig (M&A), Rolf Tichy (IP)


13. December 2023
ARQIS launches focus group Regulatory and promotes Friedrich Gebert to equity partner

ARQIS is starting into the new year with a new focus group for regulated industries. The focus group called Regulatory will be led by Dr. Friedrich Gebert , who will also be promoted to equity partner as of January 2024.

Regulatory will cover public commercial law, including environmental and planning law, energy law and other specialized areas, as well as issues around the circular economy. The members of the focus group combine their advise on transactions as well as on major industrial projects in the energy, transport and digital economy/platform economy sectors. The group provides comprehensive advice on sustainability, ESG and EU Green Deal requirements. This also includes product-related (compliance) advice, for example in relation to the Ecodesign Directive and product law.

After several years with Freshfields Bruckhaus Deringer and Posser Spieth Wolfers & Partners, Friedrich Gebert joined ARQIS in 2021 and became a partner in 2022. Over the past two years, he has built the public & regulatory law department at ARQIS and, in addition to advising on environmental and planning law and litigation, has set a his focus on EU Green Deal issues, particularly in the energy and transport sectors. The team now consists of seven lawyers in Düsseldorf and the newly found ARQIS Talent Hub in Berlin, which opened in 2022 and which is headed by Friedrich Gebert.

“The goal of climate neutrality and the associated transformation of almost all sectors of the economy is associated with a wealth of regulatory requirements for companies. In line with our holistic, future-oriented advisory approach, we help our clients to adapt their business models to the new legal requirements and to establish new business models,” says Managing Partner Dr Andrea Panzer-Heemeier. “The particular strategic relevance of regulatory advice for ARQIS, together with the very successful development work that Friedrich Gebert and his team have carried in this area, is now reflected in a new focus group of the firm.”

“In no other area will European lawmakers make as many adjustments in the coming decades as in the area of Green Deal regulation,” says Friedrich Gebert. “Our goal is to advise companies and the public sector in a forward-looking and individualized way so that they can compete and shape the green transition as positively as possible for themselves and for our society.”

Regulatory is the sixth ARQIS focus group. Since 2020, the expertise of a total of 80 lawyers and legal specialists has been bundled in the Transactions, HR.Law, Japan, Data.Law, and Risk groups.


8. December 2023
ARQIS advises ARCHIMED on purchase of Proinnovera and simultaneous merger with Symbio

ARQIS has advised global private equity healthcare specialist ARCHIMED on the acquisition of Germany-based full-service Contract Research Organization (CRO) Proinnovera. The purchase built the platform for the further acquisition of US-based CRO Symbio (for ARCHIMED advised by White & Case) and the successful merger of the two companies.

Proinnovera and Symbio are offering cost saving, time-efficient outsourced services for dermatological therapy formulation and clinical trial testing. The merged group, Symbio Proinnovera, provides consulting, testing and clinical research through every development stage, from conception to global regulatory approval and commercialization. Symbio Proinnovera aims to contribute to shorter trials and lower costs for clients (ultimately giving the public faster and cheaper access to innovative drugs) using its extensive dermatological testing database. Acquisitions should further accelerate company growth.

The ARQIS team led by partner Dr Jörn-Christian Schulze has been advising ARCHIMED for many years, most recently on the acquisition of the ZytoMax Group. Schulze's team has many years of successful experience, particularly in the healthcare and technology sector.

 

 

Advisors to ARCHIMED for the acquisition of Proinnovera

ARQIS (Dusseldorf): Dr. Jörn-Christian Schulze ARQIS (Düsseldorf): Dr. Jörn-Christian Schulze (Lead), Christos Choudeloudis (both Private Equity); Partner: Dr. Ulrich Lienhard (Real Estate), Tobias Neufeld (Data Law), Dr. Astrid Seehafer (Product Law); Counsel: Sina Janke (Compliance), Jens Knipping (Tax), Anja Mehrtens (Labour Law); Managing Associates: Dr. Hanna Caesar (Labour Law), Kamil Flak (Private Equity), Nora Stratmann (IP); Associates: Tim Bresemann (Real Estate), Jasmin Grünen (Private Equity/Tax), Thomas Lipsky (IP), Katrin Ludwig (Private Equity), Eva Ritte (Product Law), Daniel Schlemann (Data Law), Severin Steffens (Private Equity), Dr. Hendrik Völkerding (Labour Law); Legal Specialist: Qing Xia (Private Equity)


7. November 2023
ARQIS advises KUKA AG on Joint Venture with Mitsubishi Electric

ARQIS has advised KUKA AG with its Finnish subsidiary Visual Components Co., Ltd. on its joint venture with Mitsubishi Electric Corporation. The joint venture called ME Industrial Simulation Software Co., Ltd., will develop and sell 3D simulators. The shareholding ratio is 70% Mitsubishi Electric and 30% Visual Components.

Visual Components is one of the pioneers of the 3D manufacturing simulation industry. In 2017, KUKA – one of the world’s leading suppliers of intelligent automation solutions – acquired Visual Components with the aim to define the next level in intelligent automation.

Mitsubishi Electric Corporation is a recognized world leader in the manufacture, marketing and sales of electrical and electronic equipment used in information processing and communications, space development and satellite communications, consumer electronics, industrial technology, energy, transportation and building equipment. In 2022 they launched the "MELSOFT Gemini" 3D simulator, which provides a digital twin platform that uses 3D to build production equipment and lines in digital space and reduces man-hours during design, equipment, and line start-up, thereby providing TCO (Total Cost of Ownership) for customers in the engineering chain of the manufacturing industry.

The joint venture aims to maximize synergies by combining Visual Components' superior 3D simulation software with Mitsubishi Electric's manufacturing know-how. The Joint Venture Partners intend to enhance the digital twin platform, accelerate the realization of digital manufacturing, and contribute to strengthening the competitiveness of their customers.

ARQIS advised KUKA AG with a combined team from the Dusseldorf and the Tokyo office. The mandate goes back to Lead Partner Dr. Lars Laeger, who has already advised KUKA on transactions in the past.

 

Advisors to KUKA AG
ARQIS (Dusseldorf): Dr. Lars Laeger (Lead; M&A), Thomas Chwalek (M&A); Counsel: Dr. Nima Hanifi-Atashgah (M&A)
ARQIS (Tokio): Ulrich Kirchhoff, Yutaka Nakagawa, Kenichi Takasugi (Corporate Law, Foreign Investment Law)

Competition Law: Evelyn Niitväli, Niitväli Competition Law

KUKA Inhouse Advisors:
KUKA Corporate Legal: Florian Dorow (Associate General Counsel), Maximilian Schmid (Senior Legal Counsel)


20. October 2023
ARQIS advises Agile Robots AG on entry in BMW subsidiary idealworks GmbH

ARQIS has advised the Munich-based technology company Agile Robots AG on its entry as majority shareholder and strategic investor in the Munich-based idealworks GmbH.

The BMW Group subsidiary, founded at the end of 2020, is a deep tech company that significantly promotes industrial automation in production and logistics by developing a robotics ecosystem. Agile Robots, a spin-off of the German Aerospace Center (DLR), produces robotic-based solutions for the consumer electronics and automotive industries. As strategic partners, idealworks and Agile Robots complement each other both in their industry expertise and in their complementary range of solutions as well as in their strive for international expansion.

The investment in idealworks offers both future partners extensive growth potential: Agile Robots is active in major regions of the world and, in addition to its expertise in robotics and artificial intelligence, provides to idealworks its global network. idealworks brings in the BMW Group as one of its largest customers as well as its industrial know-how. Following the first successfully completed customer projects in the USA, idealworks global business will expand to the Asia-Pacific region as early as next year.

In a dynamic competitive environment, both companies rely on cross-process platforms that enable the simultaneous integration of several robots – including devices from third-party providers. Artificial intelligence is a key success factor when using heterogeneous robot fleets in complex environments and when creating digital twins for planning and simulation purposes.

The transaction is subject to prior approval by the relevant authorities. Financial details of the transaction will not be disclosed.

The ARQIS team, led by Dr. Christoph von Einem has been supporting Agile Robots since its foundation in its own financing rounds as well as in strategic partnership agreements with large companies.

 

Advisors to Agile Robots

ARQIS (Düsseldorf/Munich): Prof. Dr. Christoph von Einem; Thomas Chwalek (both Lead Transaction, Corporate M&A), Marcus Nothhelfer (IP/IT; Commercial), Dr. Friedrich Gebert (Foreign Trade Law; Public Law), Dr. Ulrich Lienhard (Real Estate), Dr. Astrid Seehafer (Regulatory Law); Counsel: Jens Knipping (Tax), Anja Mehrtens (Labour Law), Dr. Nima Hanifi-Atashgah (Corporate/M&A); Managing Associate: Benjamin Bandur (Corporate/M&A; Lead Due Diligence), Nora Stratmann (Commercial); Associate: Conrad Wiza, Jasmin Grünen, Anselm Graf (all Corporate M&A), Rolf Tichy, Thomas Lipsky (both IP/IT), Dr. Bernhard Gröhe (Foreign Trade Law; Public Law), Dennis Ratschkowski (Tax), Dr. Hendrik Völkerding (Labour Law), Tim Bresemann (Real Estate), Eva Ritte (Regulatory Law); Legal Specialist: Konstantinos Strempas

Antitrust law: Marck Rechtsanwälte, Dr. Georg Schmittmann

BMW Deal Team:

Inhouse Law: Stefan Hienzsch (Assistant General Counsel, Lead); Dr. Matthias Wahl, Sascha Ostermann (both Corporate M&A); Dr. Anne Frick, Christian Duca (both IP)

Hogan Lovells (Antitrust, Foreign Trade Law): Dr. Christoph Wünschmann (Lead, Antitrust, Munich); Dr. Falk Schöning, Stefan Kirwitzke (both Foreign Trade Law, Brussels)


19. October 2023
ARQIS advises Physio CKI on the entry of Kapital 1852

ARQIS has advised the physiotherapy practice group Physio CKI on its expansion and the entry of growth partner Kapital 1852.

As part of a combined succession plan and expansion financing, the investment company Kapital 1852 Beratungs GmbH with the fund Kapital 1852 SCS SICAV-SIF Equity Invest IV “MidCapPlus” took a majority stake in the Physio CKI practice group.

Physio CKI, based in Bonn, employs over 100 professionals, over 70 percent of whom are therapeutic, and sees itself as a partner to its patients in the areas of therapy, well-being, and wellness. Within a few years of its foundation, Physio CKI is one of the largest regional market participants. The aim of the cooperation is to expand the group’s proven practice concept to further locations in the Rhine-Sieg and Cologne-Bonn metropolitan areas to strengthen healthcare in the region. Investments in the digitalisation of the company are also intended to make the services more accessible and improve the patient experience.

The founders of Physio CKI were accompanied in the transaction by Livingstone Partners (Christian Grandin, Philip Dorsemagen and Felix Baust) as M&A advisors. The ARQIS team led by Dr Jörn-Christian Schulze was invited to pitch on Livingstone´s recommendation, as ARQIS has particular healthcare expertise. In the healthcare and nursing sector, the ARQIS team has many years of experience in successfully accompanying financial investors.

 

Advisors to Physio CKI

ARQIS (Düsseldorf/Munich): Dr. Jörn-Christian Schulze (Lead), Christos Choudeloudis (Internal restructuring, deal team), Thomas Chwalek, Johannes Landry, Dr. Christof Alexander Schneider (all Corporate/M&A), Dr. Ulrich Lienhard (Real Estate); Counsel: Jens Knipping (tax), Donata Lasson, Anja Mehrtens (both Labour Law); Managing Associates: Dr. Maximilian Backhaus, Malte Griepenburg (both Corporate/M&A), Franziska Weinzierl (Real Estate); Associates: Laura Ally Rizzi, Katrin Ludwig, Severin Steffens (all Corporate/M&A), Tim Bresemann, Diana Puchowezki (both Real Estate), Rolf Tichy (IP), Virginia Mäurer, Dennis Ratschkowski (Labour Law)


10. October 2023
ARQIS is “employer of the future”

The German Innovation Institute for Sustainability and Digitalisation (Deutsches Innovationsinstitut für Nachhaltigkeit und Digitalisierung, DIND) has named ARQIS “employer of the future” .

 

In cooperation with the DUP magazine and DUB.de, DIND has launched the “employer of the future” initiative for German SMEs. The patron of the initiative is Brigitte Zypries, former Federal Minister of Economics. DIND supports companies to be fit for the future. To this end, DIND cooperates with experts from business, science and politics, conducts studies on behalf of partners and assesses companies with regard to their future viability.

 

In a Smart Company Check, the status quo of the law firm was analysed by means of a questionnaire. The digital touchpoints and the brand presence of ARQIS were evaluated and extensive social listening was carried out. The result confirmed it: ARQIS is an “employer of the future”. According to the German Innovation Institute, companies that receive this label are characterised by the following: “Employers of the future have a modern digital presence, are innovative and offer contemporary working conditions”. Being named as an employer of the future shows where it is worth applying. The mention not only shows the strengths of companies, but it also helps with the recruiting of new talents, as well as for the identification, motivation and retention of employees.

 

In addition to this successful new award, the outstanding working conditions and development prospects for staff at ARQIS were also honored by other platforms. The law firm was named “Employer of the Future 2023” by the talent platform talentrocket.de and since 2022 ARQIS has been a “Fair Company”, according to the initiative for career starters and young professionals by the Handelsblatt. ARQIS has been listed as a “Young Talent Sponsor” by Iurastudent.de since 2021.


9. October 2023
ARQIS advises ACC on investment in brocolor LACKFABRIK GmbH

ARQIS has advised the pan-European investment company Active Capital Company (ACC) on the acquisition of a majority stake in Brocolor Lackfabrik GmbH and Brocolor® Immobilien GmbH (Brocolor) from ELSAN Holding B.V..

 

Brocolor, based in Gronau, is a German specialty chemicals company for paints, adhesives, primers, coatings, and other chemical products. The company has expanded its warehouse in 2019 and plans to further increase its production capacity in the short term to meet increasing customer demand. The strategic growth plan focuses on expanding its high-quality contract manufacturing service. In addition, Brocolor is considered a specialised market leader with the highest environmental, social and governance standards.

 

ACC’s entry continues its growth in Germany, leveraging its hands-on investment approach and strong track record of investing in chemical-focused companies.

 

ARQIS has acted for ACC on several occasions in the past, most recently in the context of the sale of its stake in the SchahlLED Group.

 

The ARQIS Team was led by Dr. Mauritz von Einem (Munich) and Dr. Christof Alexander Schneider (Düsseldorf) (both Corporate/M&A), plus Johannes Landry (Financing), Marcus Nothhelfer (IP, Commercial). Counsel/Associates: Benjamin Bandur (Munich), Carolin Schlütter-Lückel (Düsseldorf, both Corporate/M&A), Dennis Reisich (Tax), Nora Stratmann (IP, Commercial – both Munich).

De Breij (Pieter Holthuis and Gaston Freijser, both Dutch corporate law) and Houthoft (Ageeth Panman and Jasmijn Harms) were also involved in the international transaction.

The seller ELSAN Holding B.V. was represented by Marktlink (Tim Rikmenspoel and Dave Kooij, both Amsterdam) and PPR & Partner Pape Rauh Rechtsanwälte PartG mbB, Düsseldorf (Benjamin Bein).


31. August 2023
Katjes acquires half a “Jokolade” with support from ARQIS

ARQIS has advised Katjes on a 50 percent stake in Schoko Winterscheidt GmbH with the JOKOLADE brand.

The well-known German show moderator and entertainer Joko Winterscheidt founded the company at the end of 2020 with the aim of improving the conditions in the production of chocolate one piece at a time. Jokolade wants to raise awareness about the abuses of modern slavery and illegal child labour. The core of the assortment consists of five types of chocolate bars whose ingredients are fair trade.

Together with the company, Katjes wants to further expand its position on the market and provide fun on the chocolate shelf. Joko Winterscheidt stands for fun and entertainment like no other in Germany, but at the same time he takes on social responsibility. Both Katjes and Joko Winterscheidt, who has been JOKOLADE’s sole shareholder up to now, have agreed to donate Katjes’ investment to the company and thus to its mission.

ARQIS regularly acts for the Katjes Group. The law firm, with a team led by ARQIS partner Jörn-Christian Schulze, has already advised the candy manufacturer several times on investments or acquisitions of various brands of confectionery.

Advisors to Katjes

ARQIS (Duesseldorf/Munich) core deal team: Dr. Jörn-Christian Schulze (lead), Laura Ally Rizzi (both Corporate/M&A), Dr. Ulrich Lienhard (Real Estate), Tobias Neufeld (Labour Law); Counsel: Jens Knipping (Tax), Anja Mehrtens (Labour Law); Associates: Christos Choudeloudis (Corporate/M&A), Sabine Müller (Labour Law), Diana Puchowezki (Real Estate), Daniel Schlemann (Data Law), Rolf Tichy (IP); Trademark Professional: Carolin von Fritsch; Legal Specialist: Qing Xia; Scientific assistant: Jan Phillip Ludwig